Analysts Warn AI‑Native Apps Could Undermine SaaS Models as Software Stocks Slide
Analysts caution that AI‑native applications from leading labs could erode the economics of traditional subscription SaaS, a risk reflected in a sharp decline in software‑sector stocks. Axon Enterprise, a hybrid hardware‑software firm, has fallen 54% from its 2025 peak while the broader software index remains flat.
Why It Matters
The warning from analysts highlights a pivotal inflection point for the SaaS industry. If AI‑native applications can deliver comparable functionality at lower cost, the subscription model that has driven SaaS valuations for a decade could face margin compression and churn pressure. Companies that successfully embed generative AI into their existing platforms may protect their recurring revenue streams, while those that lag risk losing market share to pure‑play AI startups. For investors, the shift reshapes risk assessments, emphasizing the need to scrutinize AI investment cycles, convertible financing, and gross‑margin trajectories.
Moreover, the Axon case illustrates how hybrid hardware‑software firms are not immune to these dynamics. Even with strong growth and a defensible moat in law‑enforcement technology, the market is penalizing perceived AI‑related execution risk. This signals that the AI‑native threat is not confined to pure‑software players but extends across the broader enterprise technology ecosystem, prompting a reevaluation of valuation multiples and capital allocation strategies.
Key Points
- Software stocks fell earlier this year on fears AI‑native apps could undercut SaaS subscription models.
- Axon Enterprise shares are down 54% from their 2025 peak and 30% YTD, while the broader software index is flat.
- Axon's gross margin slipped 430 basis points to 71.3% as professional‑services revenue mix increased.
- The company raised a $1 billion convertible note last month to fund AI product development.
- Axon's price‑to‑sales multiple fell from ~30x to 12x, reflecting heightened valuation pressure.
Analysis
The current market reaction underscores a broader strategic dilemma for SaaS firms: double‑down on AI integration or risk obsolescence. Historically, SaaS growth has hinged on the predictability of subscription revenue and the stickiness of platform lock‑in. Generative AI threatens that lock‑in by enabling customers to build bespoke workflows without relying on a single vendor's stack. Companies that can embed AI as a value‑added layer—rather than a replacement—are likely to preserve net‑revenue retention and defend gross margins. Axon's 36% segment growth suggests that AI can be a catalyst, but the accompanying margin dip warns that scaling AI features incurs cost and operational complexity.
Investors are also recalibrating the risk‑reward calculus around balance‑sheet leverage. The $1 billion convertible note provides Axon with runway to accelerate AI development, yet it introduces dilution risk and signals that cash flow is being sacrificed for growth. In a market where SaaS multiples have already compressed, any hint of margin erosion can trigger sharp price corrections, as seen with Axon's slide from a 30x to a 12x price‑to‑sales ratio.
Looking forward, the sector's ability to assimilate AI will likely bifurcate. Firms that treat AI as a core, native capability—building proprietary models and integrating them tightly into their product roadmap—may emerge with reinforced moats and higher ARR multiples. Conversely, those that merely bolt AI onto legacy platforms risk becoming commoditized, with investors demanding deeper discounts. The upcoming earnings season will be a litmus test: firms that can demonstrate sustainable margin expansion alongside AI‑driven growth will validate the subscription model's resilience, while others may see their valuations erode further.